Early atherosclerosis detection in asymptomatic patients: A comparison of carotid ultrasound, coronary artery calcium score, and coronary computed tomography angiography

Canadian Journal of Cardiology

Volumn 29, Issue 12, 2013, Pages 1687-1694

  Schroeder, Benjamin ^a   Francis, Gordon ^a   Leipsic, Jonathon ^a   Heilbron, Brett ^a   John Mancini, G B ^a   Taylor, Carolyn M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; C REACTIVE PROTEIN; GLUCOSE;

ADULT; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY ECHOGRAPHY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY CALCIUM SCORE; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; XANTHOMA;

ADULT; AGED; BRITISH COLUMBIA; CALCINOSIS; CAROTID STENOSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84888224621     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.10.003     Document Type: Article

References (26)

1. Pitt B., Rubenfire M. Risk stratification for the detection of preclinical coronary artery disease. Circulation 1999, 99:2610-2612.
2. Grover S.A., Coupal L., Xiao-Ping H. Identifying adults at increased risk of coronary disease. JAMA 1995, 274:801-806.
3. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. NEngl J Med 1996, 335:1001-1009.
4. Keenan N.L., Shaw K.M. Centers for Disease Control and Prevention (CDC). Coronary heart disease and stroke deaths - United States, 2006. MMWR Surveill Summ 2011, 60(suppl):62-66.
5. Anderson T.J., Grégoire J., Hegele R.A., et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013, 29:151-167.
6. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106:3143-3421.
8. Cleeman J.I. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
9. Peters S.A., den Ruijter H.M., Bots M.L., Moons K.G. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012, 98:177-184.
10. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. JAm Coll Cardiol 2007, 49:378-402.
11. Anderson TJ, Grégoire J, Hegele RA, etal. Supplement to 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Available at: Accessed October 23, 2013. http://download.journals.elsevierhealth.com/mmcs/journals/0828-282X/PIIS0828282X12015103.mmc1.pdf.
12. European Association for Cardiovascular Prevention and Rehabilitation, Reiner Z., Catapano A.L., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818.
13. Shah P.K. Screening asymptomatic subjects for sublinical atherosclerosis can we, does it matter, and should we?. JAm Coll Cardiol 2010, 56:98-105.
14. Lloyd-Jones D.M., Nam B.H., D'Agostino R.B., et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults - a prospective study of parents and offspring. JAMA 2004, 291:2204-2211.
15. Raff G.L., Abidov A., Achenbach S., et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. JCardiovasc Comput Tomogr 2009, 3:122-136.
16. Otton J.M., Lønborg J.T., Boshell D., et al. Amethod for coronary artery calcium scoring using contrast-enhanced computed tomography. JCardiovasc Comput Tomogr 2012, 6:37-44.
17. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. JAm Coll Cardiology 1990, 15:827-832.
18. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim Carotid Intima-Media Thickness Consensus (2004-2006). Cerbrovasc Dis 2007, 23:75-80.
19. Lester S.J., Eleid M.F., Khandheria B.K., Hurst R.T. Carotid intima-media thickness and coronary artery calcium score as indicators of subclinical atherosclerosis. Mayo Clin Proc 2009, 84:229-233.
20. Folsom A.R., Kronmal R.A., Detrano R.C., et al. Coronary artery calcification compared with carotid intima-media thickness in prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 168:1333-1339.
21. Brook R.D., Bard R.L., Patel S., et al. Anegative carotid plaque area test is superior to other non-invasive atherosclerosis studies for reducing the likelihood of having significant coronary artery disease. Arterioscler Thromb Vasc Biol 2006, 26:656-662.
22. Sillesen H., Muntendam P., Adourian A., et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging 2012, 5:681-689.
23. Bots M.L., Baldassarre D., Simon A., et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?. Eur Heart J 2007, 28:398-406.
24. McGill H., McMahan C.A., Zieske A.W., et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000, 102:374-379.
25. Spence J.D., Eliasziw M., DiCicco M., Hackam D.G., Galil R., Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002, 33:2916-2922.
26. Johnsen S.H., Mathiesen E.B., Joakimsen O., et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromso Study. Stroke 2007, 38:2873-2880.